partners pic
HomeSite MapContact Us
14 records found
page 1 of 1
Ariel University R&D Co. is the tech transfer office of Ariel University. Ariel R&D works to commercialize the cutting edge research and technology currently being developed by the University. This ensures that technology developed by the university makes its way to the market place where it may benefit consumers.

Its core activities include technology scouting on campus, raising seed money for applied research, patent protection of assets and the commercialization of university developed technology.

The company has already had several successes with tens of millions dollars being invested in various projects in the field of clean energy such as ETV which focuses on the automotive industry and specializes in developing a high power revolutionary battery which can be used in cars. Other successful spinoffs include a device for robotic surgery and telemedicine that has raised millions of dollars of investment.
BIRAD – Research & Development Company Ltd. was established in order to translate new inventions made at Bar-Ilan University into useful products that can be effectively commercialized, thus strengthening the economy, promoting innovation and improving lives. Our innovative approach, combined with Bar-Ilan University’s rapid growth, including the largest Nanotechnology center in Israel and new Medical School in Tzfat, provides

BIRAD with a wide range of opportunities. Thus, we offer corporate partnerships and alliances, intellectual property management, and technology commercialization through venture creation and licensing.

Project focus: biotechnology, cleantech, communications, computer science, electronics, pharmacology, brain research, materials, nanotechnology.
As the technology transfer company of Ben-Gurion University of the Negev, BGN Technologies is responsible for commercializing the know-how and inventions of the University's researchers. Through the development of novel University technologies and creative partnering with industry and investors, BGN brings value to the technological marketplace.

Project focus: biotechnology, cleantech, communications, computer science, electronics, life sciences, materials, nanotechnology.
BioRap Technologies Ltd., the technology transfer company of the Rappaport Research Institute, promotes technologies and innovative perspectives in the area of biomedicine. Established in 2001 in Haifa, Israel, BioRap combines research and development activities with a commercial approach. It introduces biotech concepts based on novel scientific insights and applied directly to critical human health care issues.

Project focus: biomedicine, health care, medicine.
Carmel-Haifa University Economic Corporation Ltd. was established in 2002 as a wholly owned subsidiary of the University of Haifa to commercialize the intellectual property generated by the University’s researchers. Carmel-Haifa identifies, promotes, and markets new technologies and projects from the University into the marketplace. It works to enhance the research activity and establish collaboration opportunities, including economic ventures, between the University and industry.

Project focus: agricultural sciences, bioinformatics, biopharm, biotech, computer science.
Founded in 1979, MIGAL (the Upper Galilee Center for Knowledge) is a regional research institute that promotes the tremendous developments in modern biology and the sciences. Situated in Kiryat Shmona, Gavish Galilee Bioapplications Ltd. maintains sole rites to MIGAL’s intellectual property. Gavish establishes and nurtures new enterprises while forging strategic alliances and establishing technology frameworks for issuing licensing agreements.

Project focus: agricultural sciences, biotechnology, environmental sciences, life sciences, natural sciences, therapeutics.
Hadasit is the technology transfer company of Hadassah Medical Organization in Jerusalem, Israel. Hadasit promotes and commercializes the vast intellectual property and R&D capabilities generated at Hadassah, one of the world’s leading health care centers. Hadasic licenses rights to its products or establishes start-up companies under the auspices of Hadassah or Hadasit Bio-Holdings Ltd., a publicly traded company on the Tel Aviv Stock Exchange (HDST).

Project focus: biomedicine, diagnostics, medical devices, pharmaceuticals.
Mor Research Applications, part of the Mor Institute family of companies is part of the Clalit Health Services, Israel’s largest health care fund. Founded in 1994, Mor provides end-to-end services from patents to commercialization for Clalit doctors and researchers. The intellectual property is conceived and developed by professionals working at Clalit medical centers and hospitals across the country, including Beilinson, Meir, Kaplan, Carmel, Soroka, Ha-Emek and Schneider.

Project focus: biotechnology, medicine, pharmaceuticals.
Ramot at Tel Aviv University Ltd. is the technology transfer company of Tel Aviv University (TAU). Ramot manages all activities related to the protection and commercialization of inventions and discoveries made by faculty, students, and other researchers of TAU. Ramot provides a dynamic interface connecting industry to leading-edge science and innovation, offering new business opportunities in a wide variety of emerging markets.

Project focus: Biotechnology, Life sciences, Medicine, Engineering, Medical devices, Physics, Biopharm, Agricultural sciences, Medical diagnostics.
The Technion offers a special combination of science and engineering; with 11 affiliated hospitals, a high-tech entrepreneurial incubator and the world-class Rappaport Faculty of Medicine. Technion's power for innovation and application has shaped a successful high-tech nation and has left its imprint on the global evolution of science and high-technology.
As the commercialization arm of the Technion Research and Development Foundation, T³ has vast expertise in IP development rights, patenting and licensing inventions and forming win-win business agreements, bringing together groundbreaking ideas with investors and entrepreneurs. Transforming scientific discovery and technological innovation into real-life applied solutions, T³ has the skill, experience and wisdom to build powerful bridges so that science, technology and pure brainpower become problem-solving solutions available to all.
By contacting T³, you can become part of a growing community of entrepreneurs, industrialists and investors who are involved in the commercialization of Technion's ground-breaking technologies.
One of the largest hospitals in Israel, the Tel Aviv Sourasky Medical Center brings together highly trained clinicians and scientists to put novel techniques and technologies into practice. The more than 1,000 M.D.s and Ph.D.s cover a number of specialties in the Center’s 60 departments, institutes, and clinics. Sourasky is widely regarded as the Israel’s leading center for trauma; adult neurosurgery; pediatric neurosurgery; orthopedic and surgical oncology; kidney-pancreas transplants, liver transplants; and microsurgery on the nervous system. An active teaching hospital, Sourasky’s clinical departments are affiliated with the Sackler Faculty of Medicine at Tel Aviv University.
(THM) the Technology Transfer Company of Sheba Medical Center, is responsible for managing the intellectual property assets of Sheba Medical Center, and nine additional Israeli Hospitals, to promote the transfer of technologies, innovation and professional know-how for society's use and benefit, and for the development of the medical and health care delivery fields.
Sheba Medical Center facilities, experience, human resources and regulations enable the a one stop shop development of a novel idea from its basic science to its product development and prototype, thus rapidly generating value to its IP for commercialization.
THM bridges the gap between academia research and industry needs by building a well-structured and organized “value creation” model, as well as several business models pending on industry: (Health IT, Medical Devices, Bio-Medical, ) and on entity (start-up, SME and Big Entity/ Pharma).

THM Strategic Principles to the Success of our Tech Transfer

► We bridge basic research to commercial Value
► We develop close interaction with researchers and industry
► We Build Strategic Capabilities
► We are a “Learning Organization” and Flexible Organization
► We understand the stakeholders need and Value creation
► We Build Collaboration & Alliances
► Our stream: Identify Need from the bedside, Basic and applicable Research-
► We develop broad and Multi-national view

THM Intellectual property's portfolio spans over therapeutics, diagnostics, medical devices and medical tools in the fields of Onco-Genetics, Hemato-Oncology, Epidemiology of Malignant Diseases and Trauma, Lipids, Diabetes, Hypertension, Onco-Surgery , including research in Breast and Colon Cancer, Regenerative medicine, Immunology, Neuro-Immunology, Alzheimer's Disease, Multiple Sclerosis and Psychiatry.
Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science, Israel’s leading research center. Yeda, in Rehovot, Israel, holds an exclusive agreement with the Institute for marketing and commercializing new developments emerging from the Institute's laboratories.

Project focus: agriculture sciences, biotechnology, chemistry, computer science, environmental sciences, electro-optics, life sciences, mathematics, nanotechnology, physics.
Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity.

Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 3,000+ inventions; licensed 950+ technologies and produced 150+ spin-off companies.

Project focus: Agriculture, Computer Science, Environmental, Life Sciences, Medicine, Nanotechnology, Pharmaceuticals.
ITTN - Israel Tech Transfer Organization